Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

The primary value of placebo controls in clinical trials is the minimization of bias.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...